title: Antimicrobial mechanism of pore-forming protegrin peptides: 100 pores to kill E. coli.
abstract: Antimicrobial peptides (AMPs), important effector molecules of the innate immune system, also provide templates for designing novel antibiotics. Protegrin, an especially potent AMP found in porcine leukocytes, was recently shown to form octameric transmembrane pores. We have employed a combination of experiments and models spanning length scales from the atomistic to the cellular level in order to elucidate the microbicidal mechanism of protegrin. Comparison of the modeling and experimental data suggests that approximately 10-100 protegrin pores are necessary to explain the observed rates of potassium leakage and Escherichia coli death in exponential-phase bacteria. The kinetics of viability loss suggest that bacterial death results largely from uncontrolled ion exchange processes and decay of transmembrane potential. However, ion exchange processes alone cannot account for the experimentally observed cell swelling and osmotic lysis-a redundant "overkill" mechanism most likely to occur in locales with high protegrin concentrations. Although our study is limited to protegrin and E. coli, the timeline of events described herein is likely shared by other AMPs that act primarily by permeabilizing microbial membranes. This work provides many of the missing links in describing antimicrobial action, as well as providing a quantitative connection between several previous experimental and simulation studies of protegrin.
authors.affiliation: Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455-0132, USA.
authors.forename: Dan
authors.initials: D
authors.lastname: Bolintineanu
authors.forename: Ehsan
authors.initials: E
authors.lastname: Hazrati
authors.forename: H Ted
authors.initials: HT
authors.lastname: Davis
authors.forename: Robert I
authors.initials: RI
authors.lastname: Lehrer
authors.forename: Yiannis N
authors.initials: YN
authors.lastname: Kaznessis
mesh_terms: D000890:Anti-Infective Agents / Q000737:chemistry / Q000494:pharmacology*; D023181:Antimicrobial Cationic Peptides / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects*; D007477:Ions / Q000378:metabolism; D008564:Membrane Potentials / Q000502:physiology; D008962:Models, Theoretical; D056004:Molecular Dynamics Simulation; D011487:Protein Conformation
chemical_list: D000890:Anti-Infective Agents; D023181:Antimicrobial Cationic Peptides; D007477:Ions